Management of recurrent urolithiasis: advances in prevention strategies
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20251770Keywords:
Recurrent urolithiasis, Kidney stones, Urolithiasis prevention, Hyperoxaluria, Genetic predisposition, Machine learningAbstract
Recurrent urolithiasis is a chronic and extremely common condition that is characterized by the development of calculi in the urinary tract. It poses a serious health burden, affecting roughly 10-15% of the world’s population and having recurrence rates of over 50% within five years. Therefore, minimizing recurrence, enhancing patient outcomes, and lowering healthcare costs all depend on effective prevention strategies. Conventional preventative strategies emphasize lifestyle modifications like drinking more water, consuming less protein and sodium, and consuming oxalate-rich foods in moderation. Pharmacological strategies such as citrate supplementation, thiazide diuretics, and allopurinol have demonstrated promise; however, new data raises doubts about the effectiveness and adverse effect profiles of some regimens. Additionally, new studies emphasize the significance of tailored interventions based on genetic susceptibility, metabolic assessment, and urine biochemistry. Prospective avenues for the future include probiotics that decrease oxalate absorption, genomic profiling techniques, and engagement of machine learning and algorithms to identify high-risk individuals. This review thoroughly explores both conventional and cutting-edge approaches to the changing field of recurrent urolithiasis prevention. It highlights how important multidisciplinary care, customized treatment planning, and routine follow-up are to the success of stone prevention.
Metrics
References
Skolarikos A, Neisius A, Petřík A, Petřík A, Somani B, Tailly T, et al. Urolithiasis. Paper presented at: EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam. 2022.
Leslie SW, Sajjad H, Murphy PB. Renal calculi, nephrolithiasis. In: StatPearls. StatPearls Publishing; 2024.
Borumandnia N, Fattahi P, Talebi A, et al. Longitudinal trend of urolithiasis incidence rates among world countries during past decades. BMC Urol. 2023;23(1):166. DOI: https://doi.org/10.1186/s12894-023-01336-0
Dirie NI, Hassan J, Hussein AO, Bashiru G, Hodo AA, Orey FAH, et al. Burden of urolithiasis: a systematic review of epidemiological and clinical trends in Somalia. Afr J Urol. 2024;30(1):64. DOI: https://doi.org/10.1186/s12301-024-00468-5
Sohgaura A, Bigoniya P. A review on epidemiology and etiology of renal stone. Am J Drug Discov Dev. 2017;7(2):54-62. DOI: https://doi.org/10.3923/ajdd.2017.54.62
Almaghlouth AK, Alqutayfi HM, Bohamad AH, Almarzooq AJ, Alamer MA, Alqattan DJ. Urolithiasis Symptoms and Risk Factors Among the General Population of Alahsa, Saudi Arabia. Cureus. 2023;15(5):e39645. DOI: https://doi.org/10.7759/cureus.39645
Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs. Eur Urol Focus. 2017;3(1):18-26. DOI: https://doi.org/10.1016/j.euf.2017.04.001
Chang CW, Ke HL, Lee JI, Yung-Chin L, Jhen-Hao J, Hsun-Shuan W, et al. Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study. J Personalized Med. 2021;11(11):1154. DOI: https://doi.org/10.3390/jpm11111154
Yang L, Wang L, Liu Y, Erhao B, Jiahao W, Long X, et al. Causal associations between 45 dietary intake habits and urolithiasis: insights from genetic studies. Translational Androl Urol. 2024;13(7):1074-84. DOI: https://doi.org/10.21037/tau-24-79
Michibata U, Maruyama M, Tanaka Y, Masashi Y, Yoshikawa HY, Takano K, et al. The impact of crystal phase transition on the hardness and structure of kidney stones. Urolithiasis. 2024;52(1):57. DOI: https://doi.org/10.1007/s00240-024-01556-5
Oner M, Koutsoukos PG, Robertson W. Kidney stone formation-Thermodynamic, kinetic, and clinical aspects. In: Water-Formed Deposits. Elsevier. 2022;511-41. DOI: https://doi.org/10.1016/B978-0-12-822896-8.00035-2
Khan SR, Pearle MS, Robertson WG, Giovanni G, Benjamin KC, Steeve D, et al. Kidney stones. Nature Rev Disease primers. 2016;2:16008. DOI: https://doi.org/10.1038/nrdp.2016.8
Halinski A, Bhatti KH, Boeri L, Jonathan C, Kaloyan D, Ayman E, et al. Stone composition of renal stone formers from different global regions. Arch Ital Urol Androl. 2021;93(3):307-12. DOI: https://doi.org/10.4081/aiua.2021.3.307
Skolarikos (Chair) A, Jung H, Neisius A, Petřík A, Kamphuis GM, Davis NF. EAU Guidelines on Urolithiasis. EAU Guidelines on Urolithiasis 2025.
Baowaidan F, Zugail AS, Lyoubi Y, Culty T, Lebdai S, Brassart E, et al. Incidence and risk factors for urolithiasis recurrence after endourological management of kidney stones: A retrospective single-centre study. Progres Urol. 2022;32(8-9):601-7. DOI: https://doi.org/10.1016/j.purol.2022.02.010
Wang K, Ge J, Han W, Dong W, Yinjuan Z, Yanhao S, et al. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urol. 2022;22(1):62. DOI: https://doi.org/10.1186/s12894-022-01017-4
Peerapen P, Thongboonkerd V. Kidney Stone Prevention. Advances in nutrition (Bethesda, Md). 2023;14(3):555-569. DOI: https://doi.org/10.1016/j.advnut.2023.03.002
Szymanski J, Chlosta M, Dudek P, et al. Prevalence, correlates, and treatment behaviors for urolithiasis and renal colic-like pain symptoms at the population level in Poland. Scientific Reports. 2025;15(1):10827. DOI: https://doi.org/10.1038/s41598-025-95504-x
Manzo BO, Cabrera JD, Emiliani E, Sánchez HM, Eisner BH, Torres JE. Impact of the adherence to medical treatment on the main urinary metabolic disorders in patients with kidney stones. Asian J Urol. 2021;8(3):275-279. DOI: https://doi.org/10.1016/j.ajur.2020.07.002
Jung HD, Cho S, Lee JY. Update on the Effect of the Urinary Microbiome on Urolithiasis. Diagnostics (Basel, Switzerland). 2023;13(5):951. DOI: https://doi.org/10.3390/diagnostics13050951
Knight J, Deora R, Assimos DG, Holmes RP. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis. 2013;41(3):187-96. DOI: https://doi.org/10.1007/s00240-013-0566-7
Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD. Role of Oxalobacter formigenes in Calcium Oxalate Stone Disease: A Study from North India. Europ Urol. 2002;41(3):318-22. DOI: https://doi.org/10.1016/S0302-2838(02)00040-4
Gambaro G. Empirical therapy or precision medicine for kidney stone formers in the ‘-omics’ era? Urolithiasis. 2019;47(1):1-3. DOI: https://doi.org/10.1007/s00240-018-1099-x
Gamage KN, Jamnadass E, Sulaiman SK, Pietropaolo A, Aboumarzouk O, Somani BK. The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades. Turki J Urol. 2020;46(1):S92-103. DOI: https://doi.org/10.5152/tud.2020.20155
Zhang Q, Guo Z, Zhang J, Liu H, Yi L. Effects of multiple fluid intake on Urolithiasis by mendelian randomization study. Scientific Rep. 2024;14(1):23682. DOI: https://doi.org/10.1038/s41598-024-73891-x
Liaquat H. A Study Regarding Citrus Juices Effect (lemonade and orange juices only) in Urolithiasis When Compared to Plain Drinking Water. Pak J Med Health Sci. 2015;9(1):239-42
Mente A, O'Donnell M, Yusuf S. Sodium Intake and Health: What Should We Recommend Based on the Current Evidence? Nutrients. 2021;13(9):3232. DOI: https://doi.org/10.3390/nu13093232
Yatabe MS, Yatabe J, Takano K, Murakami Y, Sakuta R, Abe S, et al. Effects of a high-sodium diet on renal tubule Ca2+ transporter and claudin expression in Wistar-Kyoto rats. BMC Nephrol. 2012;13:160. DOI: https://doi.org/10.1186/1471-2369-13-160
Ticinesi A, Nouvenne A, Maalouf NM, Borghi L, Meschi T. Salt and nephrolithiasis. Nephrol Dialysis Transplantation. 2014;31(1):39-45. DOI: https://doi.org/10.1093/ndt/gfu243
Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN. Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones. Clin J Am Soc Nephrol. 2016;11(10):1834-44. DOI: https://doi.org/10.2215/CJN.01520216
Kanbara A, Miura Y, Hyogo H, Chayama K, Seyama I. Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid. Nutrition J. 2012;11(1):39. DOI: https://doi.org/10.1186/1475-2891-11-39
Skolarikos (Chair) A, Jung H, Neisius A, Petřík A, Kamphuis GM, Davis NF. EAU Guidelines on Urolithiasis. EAU Guidelines on Urolithiasis 2025.
Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, et al. Dietary oxalate and kidney stone formation. Am J Physiol-Renal Physiol. 2019;316(3):F409-13. DOI: https://doi.org/10.1152/ajprenal.00373.2018
An L, Shujue L, Zhenglin C, Min L, Zhican H, Peng X, et al. Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet. Gut Microbes. 2025;17(1):2457490. DOI: https://doi.org/10.1080/19490976.2025.2457490
Güler Y. Effects of body mass index on urinary lithogenic factors in urinary system stone patients. Folia Medica. 2024;66(1):80-7. DOI: https://doi.org/10.3897/folmed.66.e114369
Zayed S, Goldfarb DS, Joshi S. Popular Diets and Kidney Stones. Advances in Kidney Disease and Health. 2023;30(6):529-36. DOI: https://doi.org/10.1053/j.akdh.2023.10.002
Dizon S, Iliescu EA, Ross Morton A. Kidney Stones. In: Huhtaniemi I, Martini L, eds. Encyclopedia of Endocrine Diseases (Second Edition). Oxford: Academic Press. 2014;365-71. DOI: https://doi.org/10.1016/B978-0-12-801238-3.03774-0
Perez-Stable E, Caralis PV. Thiazide-induced disturbances in carbohydrate, lipid, and potassium metabolism. Am Heart J. 1983;106(1-2):245-51. DOI: https://doi.org/10.1016/0002-8703(83)90124-2
Ghazaani MZ, Rizi FSD, Malekpour E, Momeni E, Abbasi F. Hydrochlorothiazide and kidney stone recurrence; an in-depth analysis of the NOSTONE trial. J Renal Injury Prevent. 2024;13(3):e32279. DOI: https://doi.org/10.34172/jrip.2024.32279
Shen J, Zhang X. Potassium Citrate is Better in Reducing Salt and Increasing Urine pH than Oral Intake of Lemonade: A Cross-Over Study. Med Sci Monitor. 2018;24:1924-9. DOI: https://doi.org/10.12659/MSM.909319
Wiegand A, Fischer G, Seeger H, Wiegand A, Fischer G, Seeger H, et al. Impact of potassium citrate on urinary risk profile, glucose and lipid metabolism of kidney stone formers in Switzerland. Clin Kidney J. 2019;13(6):1037-48. DOI: https://doi.org/10.1093/ckj/sfz098
Krieger NS, Asplin JR, Frick KK, Ignacio G, Christopher DC, Adeline N, et al. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria. J Am Society Nephrol. 2015;26(12):3001-8. DOI: https://doi.org/10.1681/ASN.2014121223
Nazzal L, Francois F, Henderson N. Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretion. Scientific Rep. 2021;11(1):16428. DOI: https://doi.org/10.1038/s41598-021-95992-7
Li X, Ellis ML, Knight J. Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse Model. Applied Environ Microbiol. 2015;81(15):5048-54. DOI: https://doi.org/10.1128/AEM.01313-15
Hoppe B, Niaudet P, Salomon R, Menghan L, Huilin L, Hyunwook K, et al. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Pediat Nephrol (Berlin, Germany). 2017;32(5):781-90. DOI: https://doi.org/10.1007/s00467-016-3553-8
Chen Y, Ling Z, Ji J. The combination of oxalic acid and uric acid degrading probiotic from traditional Chinese fermented food reduces calcium accumulation and prevents kidney stones formation in rats. Food Biosci. 2024;62:105099. DOI: https://doi.org/10.1016/j.fbio.2024.105099
Wigner P, Bijak M, Saluk-Bijak J. Probiotics in the Prevention of the Calcium Oxalate Urolithiasis. Cells. 2022;11(2). DOI: https://doi.org/10.3390/cells11020284
Ma J, Lyu Y, Liu X. Engineered probiotics. Microbial Cell Factories. 2022;21(1):72. DOI: https://doi.org/10.1186/s12934-022-01799-0
Elshamaa MF, Fadel FI, Kamel S, Farouk H, Alahmady M, Ramadan Y. Genetic polymorphisms in CLDN14 (rs219780) and ALP (rs1256328) genes are associated with risk of nephrolithiasis in Egyptian children. Turk J Urol. 2021;47(1):73-80. DOI: https://doi.org/10.5152/tud.2020.20141
Lovegrove CE, Goldsworthy M, Haley J, Diane S, Caroline G, Fadil MH, et al. Genetic variants predisposing to increased risk of kidney stone disease. J Clin Investigation. 2025;e186915. DOI: https://doi.org/10.1101/2024.06.07.24308490
Rusu EE, Sorohan BM, Pandele R, Andreea Popescu 1, Raluca Bobeica 2, Sonia Balanicaet al. Phenotypes and the Importance of Genetic Analysis in Adult Patients with Nephrolithiasis and/or Nephrocalcinosis: A Single-Center Experience. Genes. 2025;16(5):501. DOI: https://doi.org/10.3390/genes16050501
Shee K, Liu AW, Chan C. A Novel Machine-Learning Algorithm to Predict Stone Recurrence with 24-Hour Urine Data. J Endourol. 2024;38(8):809-16. DOI: https://doi.org/10.1089/end.2023.0457
Doyle P, Gong W, Hsi R, Kavoussi N. Machine Learning Models to Predict Kidney Stone Recurrence Using 24 Hour Urine Testing and Electronic Health Record-Derived Features. Research square. 2023. DOI: https://doi.org/10.21203/rs.3.rs-3107998/v1
Mahmoodi F, Andishgar A, Mahmoudi E, Monsef A, Bazmi S, Tabrizi R. Predicting symptomatic kidney stones using machine learning algorithms: insights from the Fasa adults cohort study (FACS). BMC Res Notes. 2024;17(1):318.
Nedbal C, Adithya S, Naik N, Gite S, Juliebø-Jones P, Somani BK. Can Machine Learning Correctly Predict Outcomes of Flexible Ureteroscopy with Laser Lithotripsy for Kidney Stone Disease? Results from a Large Endourology University Centre. Eur Urol Open Sci. 2024;64:30-7. DOI: https://doi.org/10.1016/j.euros.2024.05.004
Alghafees MA, Abdul Rab S, Aljurayyad AS. A retrospective cohort study on the use of machine learning to predict stone-free status following percutaneous nephrolithotomy: An experience from Saudi Arabia. Ann Med Surg. 2022;84:104957. DOI: https://doi.org/10.1016/j.amsu.2022.104957
Mahmoodi F, Andishgar A, Mahmoudi E, Monsef A, Bazmi S, Tabrizi R. Predicting symptomatic kidney stones using machine learning algorithms: insights from the Fasa adults cohort study (FACS). BMC Res Notes. 2024;17(1):318. DOI: https://doi.org/10.1186/s13104-024-06979-2
Abraham A, Kavoussi NL, Sui W, Bejan C, Capra JA, Hsi R. Machine Learning Prediction of Kidney Stone Composition Using Electronic Health Record-Derived Features. J Endourol. 2022;36(2):243-50. DOI: https://doi.org/10.1089/end.2021.0211
Malieckal DA, Ganesan C, Mendez DA, Pao AC. Breaking the Cycle of Recurrent Calcium Stone Disease. Adv Kidney Dis Heal. 2023;30(2):164-76. DOI: https://doi.org/10.1053/j.akdh.2022.12.004
Burns Z, Knight J, Fargue S, Holmes R, Assimos D, Wood K. Future treatments for hyperoxaluria. Curr Opin Urol. 2020;30(2):171-6. DOI: https://doi.org/10.1097/MOU.0000000000000709
Downloads
Published
How to Cite
Issue
Section
